cellulite

Ultherapy With Radiesse Reduces Appearance of Cellulite

New combination treatment targets skin dimples and laxity

Patients with cellulite and skin laxity who underwent treatment with microfocused ultrasound with visualization (MFU-V; Ultherapy) in combination with diluted calcium hydroxylapatite (CaHa; Radiesse) saw a significant improvement in laxity and a significant reduction in dimpling.

Gabriel Casabona, MD, and Gregorio Pereira, MD, published the results of their retrospective study of 20 female patients (mean age: 40.0 ± 8.2 years; mean BMI 21.5 ± 1.5 kg/m2) in Plastic and Reconstructive Surgery – Global Open (July 2017).

Cellulite Reducer

Main Image: 
Cellulite Reducer

The EndyMed Contour handpiece is FDA cleared for temporary reduction in the appearance of cellulite and temporary improvement of local blood circulation, allowing for faster cell metabolism and fat elimination. It combines 3DEEP radiofrequency with an electronically controlled modulated vacuum (ECMV), modulated massage function, precise digital controls and real-time temperature tissue impedance monitoring to safely contour and tighten.

Contact: 855.363.9633, www.endymed.com.

No, don't share this with BeautyEtc
Article free tagging: 
Articles: 

Smooth Operators

How to manage expectations and identify the best candidates for minimally invasive and noninvasive cellulite treatment options.
Smooth Operators

Cellulite. The very word makes women—and some men—cringe. It’s a condition that affects people of all ages and body types. For decades, treatment options have been numerous and sometimes downright medieval, ranging from machines that vibrate wide canvas belts surrounding the hips and buttocks electrical muscle stimulators, mechanical massage, and a host of creams, serums and injectables. The problem: Until recently, no treatment modality has offered long-term results.

Phase 2b Trials Initiated for Injectable Cellulite Solution

Phase 2B Trials Initiated for Injectable Cellulite Solution

Pharmaceutical company Endo International has announced the initiation of its Phase 2b study of collagenase clostridium histolyticum (CCH) for the treatment of edematous fibrosclerotic panniculopathy (EFP), commonly known as cellulite. CCH (currently known as XIAFLEX) is a biologic approved in the U.S., EU, Canada, Australia and Japan for the treatment of adult Dupuytren’s contracture (DC) patients with a palpable cord, and in the U.S. and EU for the treatment of adult men with Peyronie's disease (PD).

Cellulite Solution

Rollout of the FDA-approved Cellfina System provides a minimally invasive, long-lasting cellulite treatment option with high patient satisfaction levels.
Cellulite Solution

“We finally have a solution for many patients who come in complaining about cellulite,” says Daniel C. Mills, MD, director of the Aesthetic Plastic Surgical Institute in Laguna Beach, California, and one of four physicians chosen by Ulthera to work on clinical applications for its latest device, Cellfina.

Cellfina System Approved by FDA

Cellfina System Approved by FDA

The U.S. Food and Drug Administration (FDA) has cleared the Cellfina System (Ulthera) for long-term improvement (up to two years) in the appearance of cellulite on the buttocks and thighs. The Cellfina System combines highly advanced, proprietary technology with subcision to treat the primary structural cause of cellulite.